Company Filing History:
1 out of 3,221 
1 out of 39 
Years Active: 2021
Title: Leonard David Goldstein: Innovator in Cancer Diagnosis and Treatment
Introduction
Leonard David Goldstein is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of cancer through innovative methods.
Latest Patents
Goldstein holds a patent for "Methods for diagnosing and treating cancer by means of the expression status and mutational status of NRF2 and downstream target genes." This invention provides methods for identifying subjects with cancer, such as lung cancer, by analyzing the expression levels of one or more NRF2 splice variants or NRF2 target genes. Additionally, it offers methods for treating cancer in subjects with a NRF2 pathway antagonist, specifically targeting those who express one or more NRF2 splice variants or overexpress one or more NRF2 target genes. He has 1 patent to his name.
Career Highlights
Throughout his career, Goldstein has worked with prominent companies in the biotechnology sector, including Genentech, Inc. and Foundation Medicine, Inc. His work has been instrumental in advancing cancer treatment methodologies.
Collaborations
Goldstein has collaborated with notable professionals in his field, including Christiaan Nicolaas Klijn and James M Lee. These collaborations have further enriched his research and contributions to cancer diagnostics and treatment.
Conclusion
Leonard David Goldstein's innovative work in cancer diagnosis and treatment exemplifies the impact of dedicated research in the medical field. His contributions continue to influence advancements in cancer therapies and diagnostics.